Edition:
United States

Genmab A/S (GEN.CO)

GEN.CO on Copenhagen Stock Exchange

906.00DKK
10:59am EDT
Change (% chg)

kr.-16.40 (-1.78%)
Prev Close
kr.922.40
Open
kr.931.40
Day's High
kr.948.00
Day's Low
kr.903.40
Volume
227,565
Avg. Vol
184,327
52-wk High
kr.1,339.00
52-wk Low
kr.823.80

Chart for

About

Genmab A/S is a Denmark-based biotechnology company. It is engaged in the development of differentiated human antibody therapeutics for the treatment of cancer, as well as other medical conditions, such as relapsing remitting multiple sclerosis. Its product pipeline includes a number of research and development projects in... (more)

Overall

Beta: 1.22
Market Cap(Mil.): kr.59,952.73
Shares Outstanding(Mil.): 61.49
Dividend: --
Yield (%): --

Financials

  GEN.CO Industry Sector
P/E (TTM): 48.87 119.85 32.14
EPS (TTM): 19.95 -- --
ROI: 20.14 1.96 12.83
ROE: 20.15 1.12 14.95

Danish biotech Genmab hit by ending of trial using key cancer drug

COPENHAGEN Shares in Danish biotech Genmab fell by as much as 25 percent on Monday after its partner Johnson & Johnson decided to ditch a study using its blockbuster cancer drug.

May 28 2018

Danish biotech Genmab hit by ending of trial using key cancer drug

COPENHAGEN, May 28 Shares in Danish biotech Genmab fell by as much as 25 percent on Monday after its partner Johnson & Johnson decided to ditch a study using its blockbuster cancer drug.

May 28 2018

Earnings vs. Estimates